ALKBH6 and pancreatic neoplasm: Altogether, these results suggest that ALKBH6 is involved in maintaining genomic integrity during SN2 alkylating agent-mediated DNA damage, and also provides a more favorable prognosis in the overall survival of pancreatic cancer patients.